J&J Reaches Deal With US For 100 Million Doses Of Over $ 1 Billion Coronavirus Vaccine


Johnson & Johnson announced on Wednesday that it will develop and deliver 100 million doses of its coronavirus vaccine to the United States in a deal totaling more than $ 1 billion.The company’s experimental vaccine is currently in the human trial phase and is expected to begin late-stage human trials in September, executives have already said. The deal gives the United States the ability to order an additional 200 million doses, according to the announcement.

“We are increasing production in the United States and around the world to provide a SARS-CoV-2 vaccine for emergency use,” said Dr. Paul Stoffels, Scientific Director at Johnson & Johnson, in a statement.

The United States previously granted J&J $ 456 million to develop its vaccine earlier this year. J&J said its goal is to deliver more than a billion doses globally by 2021.

J&J is one of the few companies to have reached an agreement with the United States to provide their potential vaccine against the coronavirus after federal approval. The United States announced Friday that it will pay drugmaker Sanofi and GlaxoSmithKline up to $ 2.1 billion to develop and deliver 100 million doses of their potential coronavirus vaccine.

The United States has also said it will pay Pfizer and biotech company BioNTech $ 1.95 billion to produce and deliver 100 million doses of their Covid-19 vaccine if it proves safe and effective, the companies announced in late July.

J & J’s vaccine candidate, Ad26.COV2.S, uses the same technology used to make its investigational Ebola vaccine, which was delivered to people in the Democratic Republic of the Congo at the end of 2019.

It’s developing news. Please check back for updates later.


Please enter your comment!
Please enter your name here